De Novo Lipogenesis (ACC/FASN/SCD1): Regulation and Validation

Three steps, three products, one shared measurement problem.

Three Steps, Three Different Products

EnzymeReactionProductNote
ACC1 (ACACA)Acetyl-CoA → malonyl-CoA, cytosolicMalonyl-CoA for FASNAlso the precursor of the CPT1A inhibitor pool
ACC2 (ACACB)Acetyl-CoA → malonyl-CoA, mitochondrial-associatedMalonyl-CoA that inhibits CPT1ALoss increases fatty acid oxidation
FASNMalonyl-CoA + acetyl-CoA → palmitateC16:0 saturated fatty acidThe committed step of synthesis
SCD1C16:0 and C18:0 → C16:1 and C18:1Monounsaturated fatty acidsDetermines membrane and esterification substrate saturation
ELOVL6C16 → C18 elongationStearate and longerOften co-regulated with SCD1

Important distinction. ACC1 and ACC2 are products of different genes with different subcellular localisation and different functions. ACC1 supplies malonyl-CoA to FASN; ACC2 supplies the malonyl-CoA pool that gates CPT1A. An ACC2 knockout increases fatty acid oxidation. A study that knocks down "ACC" without specifying the isoform has not defined what it perturbed, and the expected direction depends entirely on which one was lost.

Caveat on SCD1. SCD1 does not change the amount of fatty acid synthesised; it changes the saturation of the product. Loss of SCD1 reduces monounsaturated species and raises saturated species at the same total synthesis. In several models this increases ER stress and lipotoxicity while reducing total lipid, which is the clearest example in this cluster of "less lipid, worse outcome".

Part 1 — Measuring Synthesis Rate

MethodWhat it measuresAssumptionLimitation
¹³C-acetate incorporation into fatty acidsFraction of newly made fatty acid from acetateAcetate reaches the cytosolic acetyl-CoA poolAcetate is also oxidised; compartment mixing
¹³C-glucose incorporationContribution of glucose carbon to synthesisGlucose is the main carbon sourceUnderestimates when glutamine contributes
Deuterated water (D₂O) incorporationTotal synthesis rate, independent of carbon sourceBody water equilibrates with the precursor poolRequires careful background correction
¹⁴C-acetate incorporationSynthesis rateSame as ¹³CRadioactive; same compartment issues
Enzyme expression or activityCapacity—Not a rate
Fatty acid speciationProduct composition—Not a rate

Readout note on D₂O. Deuterium incorporation measures the number of C–H bonds formed during synthesis and is therefore closer to a true synthesis rate than tracer incorporation from a single carbon source, because it does not depend on which substrate supplied the carbon. It requires accurate measurement of the precursor enrichment and a background correction from a non-synthesising control; done properly, it is the strongest of these methods.

The weakest, and the most common, is enzyme expression. FASN and ACC1 are transcriptionally regulated by SREBP1c and by carbohydrate response elements, so expression tracks the nutritional state; it does not track flux when substrate supply changes independently.

Part 2 — What Each Perturbation Actually Does

PerturbationExpected synthesisExpected saturationExpected toxicity
ACC1 knockdownDownUnchanged or downOften down, if synthesis was driving storage overload
ACC2 knockoutUnchangedUnchangedOften down, because oxidation rises
FASN knockdownDownDownVariable; depends on whether membrane synthesis is limiting
SCD1 knockoutUnchangedSaturated species upOften up, through ER stress and membrane rigidification
SCD1 overexpressionUnchangedMonounsaturated upOften down, in saturated-fatty-acid models
Acetyl-CoA supply reduced (ACLY knockdown)DownDownDown, but confounded by reduced histone acetylation

The fourth and fifth rows are the clinically relevant ones: SCD1 is a widely pursued target, and its loss produces the opposite of the intended effect in several lipotoxicity models. Any SCD1 programme needs to measure ER stress and species saturation, not only total lipid.

Caveat on ACLY. ACLY supplies cytosolic acetyl-CoA for both lipogenesis and histone acetylation. A knockdown reduces both, and the resulting phenotype cannot be attributed to lipid synthesis without a rescue that restores the acetyl-CoA pool independently.

Part 3 — Regulation: Two Transcriptional Arms

ArmActivatorTargetsTimescale
SREBP1cInsulin, LXR, carbohydrateACC1, FASN, SCD1, ELOVL6Hours
ChREBPGlucose (via xylulose-5-phosphate)ACC1, FASN, ChREBPβHours
Post-translationalAMPK phosphorylates ACC1/ACC2Acute inhibition of ACC activityMinutes
AllostericCitrate activates ACC; palmitoyl-CoA inhibitsAcuteMinutes

Important distinction. Transcriptional and post-translational regulation act on different timescales and are measured differently. A 30-minute change in malonyl-CoA is a phosphorylation event; a 24-hour change in FASN protein is a transcriptional one. An experiment that measures protein at 24 hours and infers flux at 1 hour has crossed the two.

Readout note on AMPK. ACC phosphorylation at S79 is the standard readout of AMPK activity toward ACC, and it reports the acute arm. It does not report flux, because ACC activity also depends on substrate and on allosteric regulators, and because phosphorylation is reversible within minutes.

Part 4 — Validation Design

StepMeasurementQuestion answered
1Synthesis rate (D₂O or tracer) at baselineHow much synthesis occurs
2Fatty acid speciationWhat is being made
3Triglyceride and phospholipid speciesWhere the product went
4ER stress and viabilityWhether the change is tolerated
5Rescue with the missing product (oleate for SCD1; palmitate for FASN)Which product mattered
6Substrate supply control (acetate, glucose, glutamine)Whether the change was supply-driven

The fifth step is decisive for SCD1 and is often omitted. If oleate restores viability in an SCD1 knockout, the lesion is desaturation; if it does not, the phenotype is downstream or unrelated to the lipid.

Part 5 — Model Requirements

RequirementWhy
Medium glucose and insulin documentedBoth drive SREBP1c and ChREBP
Serum lot and lipid contentLipoprotein lipids suppress synthesis
Oxygen tensionSynthesis consumes NADPH and acetyl-CoA; hypoxia shifts the balance
Fatty acid supplementation recordedExogenous fatty acids suppress de novo synthesis
Proliferation measuredMembrane synthesis demand drives lipogenesis in dividing cells
Isotope precursor enrichment measuredOtherwise incorporation is uninterpretable

The fourth row is a common confound: cells cultured in medium with added palmitate or serum lipids downregulate de novo synthesis, so a "low lipogenesis" phenotype may reflect the medium rather than the genotype.

Part 6 — Failures That Recur

  • • "ACC" without isoform specification, so the expected direction is undefined.
  • • Expression reported as synthesis rate.
  • • SCD1 loss interpreted as reduced lipogenesis, when the amount is unchanged and the composition shifted.
  • • Rescue with oleate omitted, leaving the mechanism untested.
  • • Acetate tracer used without measuring precursor enrichment, or in cells that oxidise acetate heavily.
  • • Serum lipids and exogenous fatty acids unrecorded.
  • • ACLY knockdown attributed to lipogenesis, when histone acetylation also fell.
  • • AMPK phosphorylation reported as ACC flux.

Part 7 — Where This Article Connects

This is the synthesis article of the lipid cluster: it feeds the esterification and storage modules described in the pillar, and it gates oxidation through the malonyl-CoA pool described in the fatty acid oxidation article. The SCD1 phenotype article covers the interpretive problem in detail; the triglyceride assay article covers the product measurement.

If you need lipogenesis measured as a rate with isotope enrichment controls, we can scope the design with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Synthesis rate, isoform expression and the partition between saturated and monounsaturated products vary with cell type, medium, insulin and proliferation. The expected directions above are conditional.

Enzyme expression does not establish synthesis rate, and a change in total lipid does not establish a change in synthesis.

Scientific interpretation and experimental design

  • • ACC1 and ACC2 are different experiments. Specify the isoform.
  • • SCD1 changes composition, not amount.
  • • Synthesis rate needs a tracer with enrichment data. Expression is not a rate.
  • • Acetate is oxidised. Compartment mixing limits its interpretation.
  • • Medium lipids suppress synthesis. Record them.
  • • Rescue with the missing product identifies the mechanism.
  • • Transcriptional and acute regulation are different timescales.

Selected references for further reading

  • • Abu-Elheiga L, et al. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001;291:2613–2616.
  • • Flowers MT, Ntambi JM. Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochimica et Biophysica Acta. 2009;1791:85–91.
  • • Hellerstein MK, Neese RA. Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. American Journal of Physiology. 1999;276:E1146–E1170.
  • • Softic S, et al. Dietary sugars alter hepatic fatty acid oxidation in mice via effects on malonyl-CoA and CPT1A. JCI Insight. 2019;4:e128760.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: